• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二级预防:我们目前的状况。

Secondary prevention: Where we are.

作者信息

Corrà Ugo, Piepoli Massimo F

机构信息

1 Division of Cardiology, Istituti Clinici Scientifici Maugeri, Italy.

2 Cardiology Department, Polichirurgico Hospital G Da Saliceto, Italy.

出版信息

Eur J Prev Cardiol. 2017 Jun;24(3_suppl):14-21. doi: 10.1177/2047487317704978.

DOI:10.1177/2047487317704978
PMID:28618902
Abstract

The Sixth Joint Task Force of the European Society of Cardiology (ESC) and Other Societies on Cardiovascular Disease Prevention in Clinical Practice Guidelines have been published in 2016: greater emphasis has been placed on a population-based approach, on disease-specific interventions and on female-specific conditions, younger individuals and ethnic minorities. The ESC guidelines underscore that a lifetime approach to cardiovascular risk is important as both risk and prevention are dynamic and continuous. The guidelines can assist healthcare professionals, patients, and are valuable for the healthcare system but implementation of secondary cardiovascular disease prevention is far from optimal. Although there is no single way to ensure the use of guidelines in practice, multifaceted interventions based on known barriers are most appropriate. Essential components for implementation are: (a) taking action; (b) strengthening capacity; (c) evaluating impact; (d) advancing policy; and (e) engaging in regional and global partnerships. The strategy depends on a balanced investment in all available intervention approaches, from policy and environmental changes designed to prevent risk factors to assurance of quality care for individuals with cardiovascular disease. Our greatest challenges represent our greatest opportunities.

摘要

欧洲心脏病学会(ESC)及其他学会关于临床实践指南中心血管疾病预防的第六联合工作组已于2016年发布:更加注重基于人群的方法、针对特定疾病的干预措施以及针对女性特定情况、年轻个体和少数民族的措施。ESC指南强调,由于风险和预防都是动态且持续的,因此采用终生心血管风险方法很重要。这些指南可帮助医疗保健专业人员、患者,对医疗保健系统也很有价值,但二级心血管疾病预防的实施远未达到最佳状态。虽然没有单一方法可确保在实践中使用指南,但基于已知障碍的多方面干预最为合适。实施的基本要素包括:(a)采取行动;(b)加强能力;(c)评估影响;(d)推进政策;(e)参与区域和全球伙伴关系。该战略取决于对所有可用干预方法进行平衡投资,从旨在预防风险因素的政策和环境变化到为心血管疾病患者提供优质护理的保障。我们最大的挑战代表着我们最大的机遇。

相似文献

1
Secondary prevention: Where we are.二级预防:我们目前的状况。
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):14-21. doi: 10.1177/2047487317704978.
2
Who needs secondary prevention?谁需要二级预防?
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):8-13. doi: 10.1177/2047487317706112.
3
Planning secondary prevention: Room for improvement.二级预防规划:仍有改进空间。
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):22-28. doi: 10.1177/2047487317704954.
4
Improving adherence to medication for secondary cardiovascular disease prevention.提高二级心血管疾病预防用药的依从性。
Eur J Prev Cardiol. 2017 Jun;24(3_suppl):29-35. doi: 10.1177/2047487317708145.
5
Joint ESC/EACTS guidelines on myocardial revascularization.欧洲心脏病学会(ESC)/欧洲心胸外科学会(EACTS)心肌血运重建指南
J Cardiovasc Med (Hagerstown). 2011 Apr;12(4):264-7. doi: 10.2459/JCM.0b013e328344e647.
6
Secondary prevention and cardiovascular care across Europe: A survey of European Society of Cardiology members' views.欧洲二级预防和心血管护理:欧洲心脏病学会会员观点调查。
Eur J Cardiovasc Nurs. 2020 Mar;19(3):201-211. doi: 10.1177/1474515119877999. Epub 2019 Sep 27.
7
Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the cardiac rehabilitation section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology.心血管疾病患者临床管理中的二级预防。转诊与实施的核心要素、标准及结局指标:欧洲心血管预防与康复协会心脏康复分会的政策声明。经欧洲心脏病学会实践指南委员会认可。
Eur J Prev Cardiol. 2014 Jun;21(6):664-81. doi: 10.1177/2047487312449597. Epub 2012 Jun 20.
8
Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.1997 年至 2007 年出院后期间冠心病二级预防的变化。克拉科夫缺血性心脏病二级预防计划和 EUROASPIRE II 和 III 调查的波兰部分的结果。
Kardiol Pol. 2009 Dec;67(12):1353-9.
9
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》(2012年版):欧洲心脏病学会及其他学会关于临床实践心血管疾病预防的第五联合工作组(由九个学会的代表及特邀专家组成)
Eur J Prev Cardiol. 2012 Aug;19(4):585-667. doi: 10.1177/2047487312450228. Epub 2012 Jul 4.
10
Identification of patients at risk of ischemic events for long-term secondary prevention.识别有缺血性事件风险的患者以进行长期二级预防。
J Am Acad Nurse Pract. 2009 Dec;21(12):677-89. doi: 10.1111/j.1745-7599.2009.00444.x.

引用本文的文献

1
Low-Density Lipoprotein Cholesterol Target Attainment in Patients With Established Cardiovascular Disease: Analysis of Routine Care Data.已确诊心血管疾病患者的低密度脂蛋白胆固醇目标达成情况:常规护理数据分析
JMIR Med Inform. 2020 Apr 2;8(4):e16400. doi: 10.2196/16400.